Cerevance Media Center

Current News

February 1, 2021

Cerevance Appoints Carrie Ann Cook as Chief Business Officer

Cerevance, today announced the appointment of Carrie Ann Cook, a global business development executive with more than 20 years of experience in the pharmaceutical industry, as chief business officer

READ FULL

February 1, 2021

Cerevance Appoints Naidong Ye, Ph.D. as Vice President and Head of Chemistry, Manufacturing and Controls

Cerevance today announced the appointment of Naidong Ye, Ph.D., a seasoned chemist with extensive pharmaceutical industry experience, as vice president and head of chemistry, manufacturing and controls (CMC).

READ FULL

December 8, 2020

Cerevance Appoints David Lubner to Board of Directors

Cerevance today announced the appointment of David Lubner, a senior finance executive with more than 25 years of experience in the life sciences industry, to Cerevance’s Board of Directors.

READ FULL

November 16, 2020

Cerevance’s CVN058 Achieves Primary Endpoint in Phase 1b Schizophrenia Cognition Study

Cerevance today announced positive results from a Phase 1b clinical trial evaluating the company’s oral compound, CVN058, in a biomarker study evaluating its potential as a treatment for cognitive impairment associated with schizophrenia (CIAS).

READ FULL

News Archive

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
No items found.

April 29, 2024

Cerevance to Participate at Wells Fargo Virtual Private Biotech Symposium

Date:
Monday, May 6, 2024
Time:
Per meeting scheduling
Location:
Virtual
Media:
Scheduled Meetings
Read full

April 29, 2024

Cerevance to Present at RBC Capital Markets 2024 Global Healthcare Conference

Date:
Wednesday, May 15, 2024
Time:
11:30 am ET
Location:
New York
Media:
Oral Presentation
Read full

April 17, 2024

Cerevance Presents at 35th Symposium on Medicinal Chemistry in Eastern England

Date:
Thursday, April 25, 2024
Time:
2:35pm BST
Location:
Hatfield, United Kingdom
Media:
Oral Presentation
Read full

Events Archive

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
No items found.

October 21, 2024

CVN424, a GPR6 Inverse Agonist, for Parkinson’s Disease and Motor Fluctuations: A Double-Blind, Randomized, Phase 2 Trial

Brice, Nicola L., Carlton, Mark, Margolin, David H., Bexon, Martin, Matthews, Kim L., Dawson, Lee A., Ellenbogen, Aaron L., Olanow, Warren C., Dubow, Jordan, and Kieburtz, Karl

Viewview

April 30, 2022

A Phase I, First-in-Human, Healthy Volunteer Study to Investigate the Safety, Tolerability, and Pharmacokinetics of CVN424, a Novel G Protein-Coupled Receptor 6 Inverse Agonist for Parkinson’s Disease

Margolin, D.H., Brice, N.L., Davidson, A.M., Matthews, K.L., Carlton, M.B.L.

Viewview

June 30, 2021

Development of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson Disease

Brice, N.L., Schiffer, H.H., Monenschein, H., Mulligan, V.J., Page, K., Powell, J., Xu, X., Cheung, T., Burley, J.R., Sun, H., Dickson, L., Murphy, S.T., Kaushal, N., Sheardown, S., Lawrence, J., Chen, Y., Bartkowski, D., Kanta, A., Hosea, N., Dawson, L.A., Hitchcock, S.H., Carlton, M.B.

Viewview

March 1, 2024

Discovery and First-time Disclosure of CVN766, an Exquisitely Selective Orexin 1 Receptor Antagonist

Glen, A., Bürli, R.W., Livermore, D., Buffham, W., Merison, S., Rowland, A.E., Newman, R., Fieldhouse, C., Miller, D.J., Dawson, L.A., Matthews, K., Carlton, M.B., Brice, N.L.

Viewview

April 5, 2024

Discovery of CVN293, a Brain Permeable KCNK13 (THIK-1) Inhibitor Suitable for Clinical Assessment

Bürli, R. W., Doyle,K. J., Dickson, L., Rowland, A., Matthews, K., Stott, A. J., Teall, M., Ossola, B., Russell, S. G., Harvey, J. R. M., Wu,Y., Narayana, L., Brice, N. L., Carlton, M., Dawson, L. A.

Viewview

February 15, 2023

Characterisation of C101248: A Novel Selective THIK-1 Channel Inhibitor for the Modulation of Microglial NLRP3-Inflammasome

Ossola, B., Rifat, A., Rowland, A., Hunter, H., Drinkall, S., Bender, C., Hamlischer, M., Teall, M., Burley, R., Barke, D., Cadwalladr, D., Dickson, L., Lawrence, J., Harvey, J., Lizio, M., Xu, X., Kavanagh, E., Cheung, T., Sheardown, S., Lawrence, C.B., Harte, M., Brough, D., Madry, C., Matthews, K., Doyle, K., Page, K., Powell, J., Brice, N.L., Bürli, R.W., Carlton, M.B., Dawson L.A.

Viewview